Human Well-being through Innovative Technology
2016년부터 지금까지,
더 나은 세상을 위해
스킴스바이오가 걸어온 길입니다.
Registration of EDN as a New Health Technology by the National Evidence-based Healthcare Collaborating Agency (NECA)
Official announcement of EDN as a New Health Technology by the Ministry of Health and Welfare
K2-EDN ELISA Kit approved by the Ministry of Food and Drug Safety (MFDS)
World's first approval of an EDN-based in-vitro diagnostic device by the MFDS
14th, Domestic Patent Registration No. 10-2033280
Method for Predicting Treatment Responsiveness in Recurrent wheeze
23th, Domestic Patent Registration No. 10-2064136
Method for Differentiating Wheezing in Respiratory Infections Using Eosinophil-Derived Neurotoxin (EDN)
Product upgrades and launch of new prototypes
4th, Registered as a partner company of ADTECH Co., Ltd.
Selected as a beneficiary company of the "Open Laboratory" program by the Ministry of Health and Welfare Joint research on K-EDN Kit
Global expansion through clinical trials in China, Japan, Vietnam, and other countries
23th, ISO 9001:2015 Certification – KS Q ISO 9001:2015
19th, Japan Patent Registration No. 6420475
MARKER FOR DIAGNOSING ASTHMA POST-BRONCHIOLITIS AND USE THEREOF
2nd, Publication of clinical trial results for EDN ELISA Kit:
Utility of serum eosinophil-derived neurotoxin (EDN) measurement by ELISA in young children with asthma. Allergol Int. (66(1): 70~74
18th, Cell line deposited at the Korean Cell Line Bank
31th, Participated in the Prototype Development Support Program organized by a University Holdings Company
10th, Domestic Patent Application No. 10-2017-0018517
Rapid Kit for Diagnosing Asthma or Allergic Disease
(RAPID KIT FOR DIAGNOSING ASTHMA OR ALLERGIC DISEASE)
Registered as a partner company with Primephodia Co., Ltd.
Tailored Global Expansion Strategy for Target Markets.
25th, China Patent Application No. 201580057894.0
Marker for Diagnosing Asthma Post-Bronchiolitis and Use Thereof
26th, Japan Patent Application No. 2017-522176
MARKER FOR DIAGNOSING ASTHMA POST-BRONCHIOLITIS AND USE THEREOF
Vietnam Patent Application No. 1-2017-01575
MARKER FOR DIAGNOSING ASTHMA POST-BRONCHIOLITIS AND USE THEREOF
11th, Registered as an Industry-Academia Cooperation Family Company with Inje University
Expanded business capabilities through contract with Hugel
Development of EDN Rapid Kit prototype for fast diagnosis
5th, Domestic Patent Registration No. 10-1611743
Biomarker for Predicting Asthma Development Post-Bronchiolitis
1st, Establishment of SKIMS BIO Co., Ltd.
11th, Domestic Patent Application No. P20160122KR-00
Method for Predicting Treatment Responsiveness in Recurrent wheeze
스킴스바이오(주)주소 : 서울특별시 노원구 상계로10길 24-1, 101호 중앙연구실(상계동, 상계백병원 인수관)
COPYRIGHT SKIMS-BIO Co.,LTD. ALL RIGHTS RESERVED
